Actively Recruiting
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
Led by Mayo Clinic · Updated on 2026-03-05
200
Participants Needed
2
Research Sites
399 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are trying to identify predictors for gastroesophageal reflux disease after sleeve gastrectomy.
CONDITIONS
Official Title
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients older than 18 years
- Body mass index (BMI) of 30 or greater kg/m2
- Able to give consent for the procedure
- No contraindications to laparoscopic sleeve gastrectomy such as gastric ulceration
You will not qualify if you...
- Presence of LA grade C or D esophagitis, Barrett mucosa, or peptic stricture
- Evidence of major motility abnormalities including achalasia, absent contractility, esophagogastric junction outflow obstruction, distal esophageal spasm, or hypertensive peristalsis
- Hiatal hernia larger than 3 cm
- History of previous esophageal or stomach surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Orlando Health
Orlando, Florida, United States, 32806
Active, Not Recruiting
2
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
E
Elizabeth Lemke
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here